Eyluxvi

aflibercept · Biolitec pharma Limited Zweigniederlassung Jena

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Eyluxvi, covering 2025-11-12 to 2025-11-12. Get the full timeline:

Most recent: EMA Authorised: Eyluxvi (aflibercept) — Biolitec pharma Limited Zweigniederlassung Jena